| Financial Year |
March 31 2023 |
| Monetary Funds |
378,837,152.51 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
35,912,006.23 |
| Accounts Receivable |
43,734,052.97 |
| Advances to Suppliers |
51,151,628.51 |
| Other Receivables |
14,787,392.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
887,522,715.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,397,728.05 |
| Total Current Assets |
1,432,798,928.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,272,567,092.11 |
| Under-construction Projects |
222,125,929.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
164,163,897.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
628,007.09 |
| Other Non-Current Assets |
44,875,372.81 |
| Sub-Total of Non-Current Assets |
1,705,196,520.33 |
| Total Assets |
3,137,995,448.69 |
| Short-Term Loans |
562,466,335.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
220,561,538.73 |
| Accounts Received In Advance |
154,433.66 |
| Employee Compensation Payable |
13,023,905.31 |
| Taxes Payable |
3,345,657.04 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,168,050.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
140,706,328.99 |
| Other Current Liabilities |
31,487,844.31 |
| Sub-Total of Current Liabilities |
1,007,016,214.44 |
| Long-term Loans |
236,297,779.19 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
123,970.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
237,126,898.64 |
| Total Liabilities |
1,244,143,113.08 |
| Paid-In Capital(Or Share Stock) |
224,691,099.00 |
| Capital Surplus |
663,487,003.24 |
| Surplus Reserve |
88,951,988.87 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
845,065,960.17 |
| Minority Stockholder's Interest |
69,635,569.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,824,216,766.59 |
| Owner's Equity（Stockholder's Equity） |
1,893,852,335.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,137,995,448.69 |
